Overview

Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella

Status:
COMPLETED
Trial end date:
2024-10-30
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the role of addition of Acetyl cysteine in the management of VAP induced by carbapenem resistant klebsiella. The primary outcome indicator is the change in modified clinical pulmonary infection score. The secondary outcome indicator is duration of mechanical ventilation.
Phase:
PHASE1
Details
Lead Sponsor:
Tanta University
Treatments:
Acetylcysteine
Anti-Bacterial Agents
Sodium Chloride